Novavax vaccine was recommended for use by the European drug regulator, a major step toward its clearance for use in the European Union
Novavax Inc.’s Covid-19 vaccine has been recommended for use by the European drug regulator, a major step toward its clearance for use in the European Union.
The European Medicines Agency on Monday said the vaccine has efficacy against symptomatic Covid-19 of around 90%. The trials were done when the Alpha and Beta variants were dominant, the EMA said. There was limited data on its effectiveness against the Delta and Omicron variants, it said.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
EU set to back Novavax Covid vaccineThe EU's drug regulator will decide Monday whether to approve a Covid jab by Novavax, which uses a more conventional technology that the US biotech firm hopes will reduce vaccine hesitancy.
Weiterlesen »
CDC Recommends Pfizer, Moderna Covid-19 Vaccines Over J&J’sHealth authorities said the rate of a rare but serious blood-clotting disorder associated with the Johnson & Johnson shot is higher than previously detected.
Weiterlesen »
U.S. administers 493.6 mln doses of COVID-19 vaccines - CDCThe United States has administered 493,632,529 doses of COVID-19 vaccines in the country as of Saturday morning and distributed 605,954,475 doses, the U.S. Centers for Disease Control and Prevention said.
Weiterlesen »
Covid jabs 'a problem across the board'Wrexham manager Phil Parkinson tells of the difficulties he and other managers face in trying to persuade vaccine-shy players to have a Covid-19 jab.
Weiterlesen »
In setback, Pfizer tests three doses of COVID vaccine for children under 5Pfizer is testing an extra dose of its COVID-19 vaccine for babies and preschoolers after preliminary research hinted the usual two doses wouldn't be enough.
Weiterlesen »
Pfizer to Push Back Its COVID-19 Vaccine for Babies and ToddlersRead about a statement from Pfizer and BioNTech, in which they explain they will now be testing a three-dose COVID-19 vaccine for the youngest age group of babies and toddlers.
Weiterlesen »